Biomedical Engineering Reference
In-Depth Information
5. Poirier, P., Giles, T.D., Bray, G.A., Hong, Y., Stern, J.S., Pi-Sunyer, F.X., Eckel, R.H.:
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.
Arterioscler. Thromb. Vasc. Biol. 26(5), 968-976 (2006). doi:
10.1161/01.ATV.0000216787.
6. Diaz, V.A., Mainous 3rd, A.G., Koopman, R.J., Geesey, M.E.: Undiagnosed obesity:
implications for undiagnosed hypertension, diabetes, and hypercholesterolemia. Fam. Med.
36(9), 639-644 (2004)
7. Mazzoni, M.C., Schmid-Schonbein, G.W.: Mechanisms and consequences of cell activation
in the microcirculation. Cardiovasc. Res. 32(4), 709-719 (1996)
8. Zhang, X., Cheng, R., Rowe, D., Sethu, P., Daugherty, A., Yu, G., Shin, H.Y.: Shear-
sensitive regulation of neutrophil flow behavior and its potential impact on microvascular
blood flow dysregulation in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 3(34),
587-593 (2014). doi:
10.1161/ATVBAHA.113.302868
9. Zhang, X., Hurng, J., Rateri, D.L., Daugherty, A., Schmid-Schonbein, G.W., Shin, H.Y.:
Membrane cholesterol modulates the fluid shear stress response of polymorphonuclear
leukocytes via its effects on membrane fluidity. Am. J. Physiol. Cell Physiol. 301(2), C451-
C460 (2011). doi:
10.1152/ajpcell.00458.2010
10. Schmid-Schonbein, G.W.: Analysis of inflammation. Annu. Rev. Biomed. Eng. 8, 93-131
(2006). doi:
10.1146/annurev.bioeng.8.061505.095708
11. Makino, A., Shin, H.Y., Komai, Y., Fukuda, S., Coughlin, M., Sugihara-Seki, M., Schmid-
Schonbein, G.W.: Mechanotransduction in leukocyte activation: a review. Biorheology
44(4), 221-249 (2007)
12. Fukuda, S., Yasu, T., Kobayashi, N., Ikeda, N., Schmid-Schonbein, G.W.: Contribution of
fluid shear response in leukocytes to hemodynamic resistance in the spontaneously hyper-
tensive rat. Circ. Res. 95(1), 100-108 (2004). doi:
10.1161/01.RES.0000133677.77465.38
13. Singer,
G.,
Granger,
D.N.:
Inflammatory
responses
underlying
the
microvascular
dysfunction
associated
with
obesity
and
insulin
resistance.
Microcirculation
14(4-5),
375-387 (2007). doi:
10.1080/10739680701283158
14. Florez, H., Castillo-Florez, S., Mendez, A., Casanova-Romero, P., Larreal-Urdaneta, C., Lee,
D., Goldberg, R.: C-reactive protein is elevated in obese patients with the metabolic syndrome.
Diabetes Res. Clin. Pract. 71(1), 92-100 (2006). doi:
10.1016/j.diabres.2005.05.003
15. Haffner, S.M.: The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular
disease. Am. J. Cardiol 97(2A), 3A-11A (2006). doi:
10.1016/j.amjcard.2005.11.010
16. Zimmermann, J., Herrlinger, S., Pruy, A., Metzger, T., Wanner, C.: Inflammation enhances
cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 55(2), 648-658
(1999). doi:
10.1046/j.1523-1755.1999.00273.x
17. Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M.: Adipose expression of tumor necrosis
factor-alpha: direct role in obesity-linked insulin resistance. Science 259(5091), 87-91
(1993)
18. Fain, J.N.: Release of interleukins and other inflammatory cytokines by human adipose
tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74,
443-477 (2006). doi:
10.1016/S0083-6729(06)74018-3
19. Gerhardt, C.C., Romero, I.A., Cancello, R., Camoin, L., Strosberg, A.D.: Chemokines
control fat accumulation and leptin secretion by cultured human adipocytes. Mol. Cell.
Endocrinol. 175(1-2), 81-92 (2001)
20. Hwang, C.S., Loftus, T.M., Mandrup, S., Lane, M.D.: Adipocyte differentiation and leptin
expression. Annu. Rev. Cell Dev. Biol. 13, 231-259 (1997). doi:
10.1146/annurev.cellbio.
21. Tilg, H., Moschen, A.R.: Inflammatory mechanisms in the regulation of insulin resistance.
Mol. Med. 14(3-4), 222-231 (2008). doi:
10.2119/2007-00119.Tilg
22. Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L., Spiegelman, B.M.: Increased
adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin
resistance. J. Clin. Investig. 95(5), 2409-2415 (1995). doi:
10.1172/JCI117936
Search WWH ::
Custom Search